Pharmally International Holding Company Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharmally International Holding Company Ltd with three other
companies in this sector in TAIWAN :
Tty Biopharm Company Limited
sales of 4.47 billion Taiwanese Dollars [US$153.77 million]
of which 65%
was Anti-Cancer Drug),
Standard Chem. & Pharm. Co Ltd
(3.94 billion Taiwanese Dollars [US$135.56 million]
of which 53%
was Pharmaceuticals), and
Formosa Laboratories, Inc
(2.76 billion Taiwanese Dollars [US$95.01 million]
of which 100%
was Active Pharmaceutical Ingredient).
During the year ended December of 2019, sales at
Pharmally International Holding Company Ltd were 5.09 billion Taiwanese Dollars (US$175.17 million).
decrease of 1.7%
versus 2018, when the company's sales were 5.18 billion Taiwanese Dollars .